| Predicate |
Object |
| contentType |
Journal Article|Research Support, Non-U.S. Gov't|Review |
| endingPage |
60 |
| issn |
1178-2013 |
| pageRange |
49-60 |
| publicationName |
International Journal of Nanomedicine |
| startingPage |
49 |
| bibliographicCitation |
Chang HI, Yeh MK. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomedicine. 2012;7():49–60. PMID: 22275822; PMCID: PMC3260950. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5971ebb8da1f6fa347b739fb0f8f7fd7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b62346dba92bc7ef255c9c599bd1057
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_440c3152b4512cb32e0249528c0132c7 |
| date |
201112 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3260950
https://pubmed.ncbi.nlm.nih.gov/22275822
https://doi.org/10.2147/ijn.s26766 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32688
https://portal.issn.org/resource/ISSN/1178-2013 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy |
| discusses |
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0012600 |